Authors:
Bourquelot, P
Buisson, C
Chanard, J
Cordonnier, D
Drueke, T
Dupuy, CA
Gin, H
Halimi, S
Hannedouche, T
Jacobs, C
Kourilsky, O
Lalau, JD
Pirson, Y
Ryckelynck, JP
Vialettes, B
Citation: P. Bourquelot et al., Report of the expert committee. ALFEDIAM and SFN. Management of end stage renal disease in diabetic patients. Short text, DIABETE MET, 26(1), 2000, pp. 81-87
Authors:
Vanzetto, G
Fouque, D
Moulin, B
Halimi, S
Kessler, M
Bayle, F
Boizel, R
Skurdens, T
Pradines, S",Hadjian,Rieckelink,"Mourad, G
Foret, M
Ruiz, J
Chanard, J
Hannedouche, T
Citation: G. Vanzetto et al., Round table on therapeutic management, NEPHROLOGIE, 21(7), 2000, pp. 383-392
Authors:
Bourquelot, P
Buisson, C
Chanard, J
Cordonnier, D
Drueke, T
Dupuy, CA
Gin, H
Halimi, S
Hannedouche, T
Jacobs, C
Kourilsky, O
Lalau, JD
Pirson, Y
Vialettes, B
Citation: P. Bourquelot et al., Management of Uremic Diabetes - Guidelines for Clinical Practice - Joint report of ALFEDIAM and the Societe de Nephrologie, DIABETE MET, 25, 1999, pp. 7-72
Authors:
Locatelli, F
Hannedouche, T
Jacobson, S
La Greca, G
Loureiro, A
Martin-Malo, A
Papadimitriou, M
Vanholder, R
Citation: F. Locatelli et al., The effect of membrane permeability on ESRD: design of a prospective randomised multicentre trial, J NEPHROL, 12(2), 1999, pp. 85-88
Authors:
Schneeberger, M
Douchet, MP
Chantrel, F
Bronner, F
Mossard, JM
Zupan, M
Hannedouche, T
Citation: M. Schneeberger et al., Pulmonary venous flow in the evaluation of the haemodynamic status in dialysed patients., ARCH MAL C, 92(10), 1999, pp. 1295-1300